Atea Pharmaceuticals (AVIR) Current Leases (2021 - 2026)
Atea Pharmaceuticals' (AVIR) quarterly Current Leases came in at $634000.0 in Q1 2026, down 21.82% year-on-year from $811000.0 in Q1 2025, and down 24.79% quarter-over-quarter from $843000.0 in Q4 2025.
Atea Pharmaceuticals (AVIR) Current Leases (2021 - 2026) Analysis & Trends
Atea Pharmaceuticals' Current Leases history runs 6 years deep, the most recent figure standing at $634000.0 for Q1 2026.
- On a quarterly basis, Current Leases fell 21.82% year-over-year to $634000.0 in Q1 2026; TTM through Mar 2026 was $634000.0, a 21.82% decrease from a year earlier, with the FY2025 full-year figure at $843000.0, up 5.37% from the prior year.
- Current Leases declined to $634000.0 in Q1 2026 per AVIR's latest filing, from $843000.0 in the prior quarter.
- Across five years, Current Leases topped out at $843000.0 in Q4 2025 and bottomed at $113000.0 in Q1 2022.
- The 5-year median for Current Leases is $760000.0 (2023), against an average of $725588.2.
- Across the five-year window, Current Leases surged 546.02% in 2023 and slipped 21.82% in 2026, its largest moves.
- Year by year, Current Leases stood at $721000.0 in 2022, then advanced by 5.41% to $760000.0 in 2023, then advanced by 5.26% to $800000.0 in 2024, then grew by 5.38% to $843000.0 in 2025, then declined by 24.79% to $634000.0 in 2026.
- Per Business Quant, the three latest AVIR Current Leases figures stand at $634000.0 (Q1 2026), $843000.0 (Q4 2025), and $832000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Atea Pharmaceuticals | 376.19 Mn | 376.19 Mn | - | 634,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 634,000.00 |
| Dec 31, 2025 | 843,000.00 |
| Sep 30, 2025 | 832,000.00 |
| Jun 30, 2025 | 821,000.00 |
| Mar 31, 2025 | 811,000.00 |
| Dec 31, 2024 | 800,000.00 |
| Sep 30, 2024 | 790,000.00 |
| Jun 30, 2024 | 780,000.00 |
| Mar 31, 2024 | 769,000.00 |
| Dec 31, 2023 | 760,000.00 |
| Sep 30, 2023 | 750,000.00 |
| Jun 30, 2023 | 740,000.00 |
| Mar 31, 2023 | 730,000.00 |
| Dec 31, 2022 | 721,000.00 |
| Sep 30, 2022 | 711,000.00 |
| Jun 30, 2022 | 730,000.00 |
| Mar 31, 2022 | 113,000.00 |
| Dec 31, 2021 | 197,000.00 |